The retrovirus XMRV is not directly involved in the pathogenesis of common types of lymphoid malignancy

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 10, 2011, Pages 2232-2236

  Waugh, Elspeth M ^a   Jarrett, Ruth F ^a   Shield, Lesley ^a   Montgomery, Dorothy ^a   Dean, Robert T G ^a   Mitchell, Andrea ^a   Greaves, Mel F ^b   Gallagher, Alice ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CHILD; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHADENOPATHY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UNITED KINGDOM; VIRUS IDENTIFICATION; XENOTROPIC MULV RELATED VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; LYMPHOMA; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS; YOUNG ADULT;

EID: 80053520517     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0561     Document Type: Article

References (25)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006;2:e25.
2. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 2009;106:16351-56.
3. Danielson BP, Ayala GE, Kimata JT. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 2010;202:1470-77.
4. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, et al. XMRV: a new virus in prostate cancer? Cancer Res 2010;70:10028-33.
5. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, et al. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009;6:92.
6. Lombardi VC, Ruscetti FW, Das GJ, Pfost MA, Hagen KS, Peterson DL, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009;326:585-9.
7. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, et al. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 2010;5:e8519.
8. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, et al. Absence of xenotropic murine leukaemia virus-related virus inUK patients with chronic fatigue syndrome. Retrovirology 2010;7:10.
9. Van Kuppeveld FJ, De Jong AS, Lanke KH, Verhaegh GW, Melchers WJ, Swanink CM, et al. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010;340:c1018.
10. Hong P, Li J, Li Y. Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 2010;7:224.
11. Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, et al. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis 2010;202:1478-81.
12. Goff SP. Rretroviridae: the retroviruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2007. P. 2000-69.
13. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M, et al. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 2009;83:7353-56.
14. Gallagher A, Armstrong AA, MacKenzie J, Shield L, Khan G, Lake A, et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999;84:442-48. (Pubitemid 29337135)
15. Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 2005;37:409-19. (Pubitemid 43030867)
16. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-23. (Pubitemid 34270055)
17. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002;13:23-9. (Pubitemid 34567397)
18. MacKenzie J, Greaves MF, Eden TO, Clayton RA, Perry J, Wilson KS, et al. The putative role of transforming viruses in childhood acute lymphoblastic leukemia. Haematologica 2006;91:240-3.
19. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
20. Barnes E, Flanagan P, Brown A, Robinson N, Brown H, McClure M, et al. Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. J Infect Dis 2010;202:1482-85.
21. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, et al. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008;43:277-83.
22. Mikovits JA, Huang Y, Pfost MA, Lombardi VC, Bertolette DC, Hagen KS, et al. Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer. AIDS Rev 2010;12:149-52.
23. Kim S, Kim N, Dong B, Boren D, Lee SA, Das GJ, et al. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 2008;82:9964-77.
24. Garson JA, Kellam P, Towers GJ. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011;8:13.
25. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010;7:111.